about
Parainfluenza virusesPrevention of influenza by targeting host receptors using engineered proteinsGlycosphingolipid-Protein Interaction in Signal TransductionGlycan array analysis of influenza H1N1 binding and release.Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patientsN-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site.Enterovirus 70 binds to different glycoconjugates containing alpha2,3-linked sialic acid on different cell lines.Characterization of a human H5N1 influenza A virus isolated in 2003.A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo.Coxsackievirus A24 variant uses sialic acid-containing O-linked glycoconjugates as cellular receptors on human ocular cells.Progress in the development of human parainfluenza virus vaccinesViral diversity in asthmaSialic acid functions in enterovirus 70 binding and infectionMutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase proteinComparison of differing cytopathic effects in human airway epithelium of parainfluenza virus 5 (W3A), parainfluenza virus type 3, and respiratory syncytial virus.Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein.Glycoconjugate glycans as viral receptors.Sulfatide is required for efficient replication of influenza A virus.Porcine Sapelovirus Uses α2,3-Linked Sialic Acid on GD1a Ganglioside as a Receptor.A dual drug regimen synergistically blocks human parainfluenza virus infection.Loss of the N-linked glycan at residue 173 of human parainfluenza virus type 1 hemagglutinin-neuraminidase exposes a second receptor-binding site.Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice.Colorimetric viral detection based on sialic acid stabilized gold nanoparticles.Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium.Receptor mimicry as novel therapeutic treatment for biothreat agents.Influenza a virus entry: implications in virulence and future therapeutics.Influenza virus-glycan interactions.Human parainfluenza viruses hPIV1 and hPIV3 bind oligosaccharides with alpha2-3-linked sialic acids that are distinct from those bound by H5 avian influenza virus hemagglutinin.Quantitative comparison of human parainfluenza virus hemagglutinin-neuraminidase receptor binding and receptor cleavageOligosaccharides as receptors for JC virus.Evidence that Receptor Destruction by the Sendai Virus Hemagglutinin-Neuraminidase Protein Is Responsible for Homologous Interference.Amino acid substitutions contributing to α2,6-sialic acid linkage binding specificity of human parainfluenza virus type 3 hemagglutinin-neuraminidase.Effects of Sialic Acid Modifications on Virus Binding and Infection.Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin-neuraminidase inhibitors.α2-3- and α2-6- N-linked sialic acids allow efficient interaction of Newcastle Disease Virus with target cells.Molecular characterization and phylogenetic analysis of human parainfluenza virus type 3 isolated from Saudi Arabia.Plasmonics-Based Detection of Virus Using Sialic Acid Functionalized Gold Nanoparticles.Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells.Inhibition of primary clinical isolates of human parainfluenza virus by DAS181 in cell culture and in a cotton rat model.Neuraminidase-deficient Sendai virus HN mutants provide protection from homologous superinfection.
P2860
Q24682952-13BA8A42-F9E4-42AC-A431-4598CE2B1E1EQ27683378-119177B4-A781-44A4-A87B-B16B7E6F40C9Q28072827-844B19E4-316F-4F76-9DDE-A9476C3846B3Q30360344-99C13E54-90F0-4729-B36B-A1BC097E7110Q30412678-DDABBA92-CF7D-410B-877C-8CC1A55CD137Q33676467-201C5524-F2B4-4DAA-9AB7-1E4B7B56DADEQ33788674-2A61C0B9-1380-408E-8B75-7027A188F191Q33908751-25F7DFD1-9247-4F7E-B0D1-5611836FD219Q33936520-C22D5EB9-863D-4902-9FEF-0F0567D3A3CAQ34006754-1AA8FCF0-3BB3-4FC5-9092-AA09FC8FFC19Q34209872-36D63D36-A66C-42FB-BEAC-F88B1F580391Q34257792-92D401DB-B72E-496C-88E1-FEB107AC3E12Q34355181-B8BFA78E-0A74-4BF6-BB46-7E4041519DBDQ35024321-E12D6966-FD15-47DD-97A0-C747F2C31D56Q35529143-900108AC-8EBA-42A7-802E-131792744FDEQ35664943-5142C416-131B-442C-93D2-EBE4A50D950AQ36194868-666C20CF-4D8F-45AA-BD76-4A1A8E9828BBQ36673169-947B68A9-91F3-4814-869E-51A35C03CF28Q36736374-0742D832-63E5-43A3-A005-31D0F3FF48B5Q36774468-1BB4B787-16C2-4DC1-A5BE-9926A53B803EQ36845779-9AB67C48-C16F-4FBA-96B6-631D9C5E642FQ37333181-1C6A36E4-A7A8-4076-A880-DE397F1F675CQ37661457-83725EFA-ABE9-4AAB-B7E0-B0E80A336593Q37743793-87B92096-13F2-450C-97F7-7F3E12CBBFF5Q37843686-DA81314A-DE21-435D-B24A-85D06031B22FQ38077952-76E7077E-6C66-41EF-A1E2-91168B2DE43AQ38233918-1B82D43F-54A7-4B24-BB25-33A33B398A06Q38301459-32C7450C-FEDB-4762-B0E9-1BFDF79E1C2EQ38315039-ABA58645-FBE7-4325-948D-9C7697E2CD4AQ38360828-4FE855CB-126C-47FB-BF68-AF0D94EAA598Q38765568-975B84FC-E312-482D-8BEF-661C1A6A7A9DQ38887566-194507D7-7B8D-40AE-8B20-A7692A2003D0Q38918781-8F96F6D2-026F-4698-9E4C-1380586249F2Q38946739-A0AF442B-B4FF-41CE-8DF9-FA0995496C7BQ39301463-5EF31652-46AA-44FE-8A9D-BB1A66B112EFQ39328806-D19BA219-620B-4B74-80ED-B8C83D2FD05EQ40298514-FE0FD43B-6681-4AF0-A4FA-F3743F878386Q41039144-712EC1D7-9EB8-4DD1-9F60-EBEA60DD8A62Q41873413-944BA7A8-EEF1-4026-9B6E-27DAE8EB740AQ42000667-6ABF2247-914F-46F4-A987-E0236B1F757F
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Receptor specificities of human respiroviruses.
@ast
Receptor specificities of human respiroviruses.
@en
type
label
Receptor specificities of human respiroviruses.
@ast
Receptor specificities of human respiroviruses.
@en
prefLabel
Receptor specificities of human respiroviruses.
@ast
Receptor specificities of human respiroviruses.
@en
P2093
P2860
P1433
P1476
Receptor specificities of human respiroviruses.
@en
P2093
M Uchikawa
R A Scroggs
T Takimoto
P2860
P304
P356
10.1128/JVI.75.10.4604-4613.2001
P577
2001-05-01T00:00:00Z